Results 211 to 220 of about 681,456 (227)

Economics as a guide to developing public policies for biosimilar pharmaceutical products

Queen Mary Journal of Intellectual Property, 2012
openaire   +1 more source

The Future of Biosimilar Insulins

Diabetes Spectrum, 2016
Ross J Bindler
exaly  

A survey of global biosimilar implementation practice conducted by the International Society of Oncology Pharmacy Practitioners

Journal of Oncology Pharmacy Practice, 2020
Emma Foreman, Himanshu Patel, Joseph Bubalo   +2 more
exaly  

Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries

European Journal of Health Economics, 2014
Valentin Brodszky, Petra Baji, Orsolya Balogh   +2 more
exaly  

Biosimilar Filgrastim Uptake And Costs Among Commercially Insured, Medicare Advantage

Health Affairs, 2019
Pinar Karaca-Mandic, Ronald S Go, Daniel J Weisdorf   +2 more
exaly  

Demonstration of Pharmacokinetic and Pharmacodynamic Equivalence in Healthy Volunteers for B12019, a New Proposed Pegfilgrastim Biosimilar

Blood, 2016
Dirk Lehnick
exaly  

Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA)

BioDrugs, 2019
J. Hermosilla, R. Sánchez-Martín, R. Pérez-Robles, A. Salmerón-García, S. Casares, J. Cabeza, L. Cuadros-Rodríguez, N. Navas   +7 more
semanticscholar   +1 more source

Pharmacokinetics and Pharmacodynamics of Biosimilar Insulins: Is Clamp Technology Fit for Purpose?

Diabetes Care, 2015
Philip Home, Home Philip
exaly  

PHARMACEUTICALS Merck deal with South Korea’s Hanwha bolsters move into biosimilars

Chemical & Engineering News Archive, 2011
openaire   +1 more source

A Phase III Efficacy and Safety Study of the Proposed Rituximab Biosimilar GP2013 Versus Rituximab in Patients with Previously Untreated Advanced Follicular Lymphoma

Blood, 2016
Wojciech Jurczak, Pratyush Giri, Pereira Juliana   +2 more
exaly